NCCI edits and bundling rules.
Our ophthalmology guide names the bundling patterns that cost practices the most. This page goes underneath them: how a PTP modifier indicator actually works, why an MUE denial needs a different appeal strategy than a PTP bundling denial, and where cataract surgery's global period quietly bundles testing that looks separately billable.
Key takeaways
- A PTP edit and an MUE are different mechanisms with different appeal paths. One compares two codes billed together; the other caps units of one code. Treating an MUE denial like a bundling denial wastes an appeal that was never going to succeed.
- Gonioscopy and tonometry aren't bundled into the eye exam anymore — that Medicare policy reversed in 1999 — but the CPT "separate procedure" label still trips up staff working off the old rule.
- The cataract global period bundles by timing, not by code. Biometry billed before the decision for surgery is separate revenue; the identical code billed the day before surgery is bundled — the date decides it.
- 67028's MUE of one unit doesn't block bilateral billing — it changes how you report it. One unit with modifier 50 under the bilateral payment adjustment, not two units, is how Medicare wants it.
PTP modifier indicators: what actually decides an outcome
Every NCCI procedure-to-procedure (PTP) edit pairs a Column One code with a Column Two code and assigns a modifier indicator deciding whether an override is even possible. Get it wrong and everything downstream — the modifier, the documentation, the appeal — is wasted effort.
| Indicator | Meaning |
|---|---|
0 | No modifier overrides the edit, ever — the Column Two code isn't separately payable under any documentation. Don't bill it, and don't spend an appeal on it. |
1 | An NCCI-associated modifier (59, or the more specific XE/XS/XP/XU) can override the edit, but only where the record independently shows a genuinely separate encounter, structure, session, or practitioner. |
9 | Retired — no longer applies. Verify the pair isn't still restricted at the CPT instructional level regardless (see 92133/92134 below). |
⚠️ The specific PTP indicator value for any individual ophthalmology code pair is published by CMS and revised quarterly; CMS's NCCI PTP Edits Lookup Tool returned access errors to automated retrieval during this build. Verify the current value there before building any pair into a scrubber rule.
MUEs and MAI: a different bundling mechanism entirely
A Medically Unlikely Edit caps the units of a single code payable for one patient on one date — it never compares two codes the way a PTP edit does, and confusing the two is why staff sometimes appeal an MUE denial with the wrong documentation. Every MUE carries its own MUE Adjudication Indicator (MAI), which decides whether the cap can be appealed at all:
- MAI 1Claim-line edit. Modifiers reporting the same code on separate lines can allow medically necessary excess units to be paid.
- MAI 2Absolute date-of-service edit. The cap can't be exceeded and the denial can't be appealed — CMS defines it as a hard policy limit, not a clinical judgment call.
- MAI 3Date-of-service edit, clinically based. Appealable with records: on redetermination, the MAC reviews whether the excess units were genuinely furnished and necessary.
67028 (intravitreal injection administration) shows how an MUE interacts with bilateral billing rather than blocking it. The code carries an MUE of one payable unit per date, and current billing-industry sourcing describes its Medicare bilateral indicator as a 150% payment adjustment — so a same-day, both-eyes injection is reported as one unit with modifier 50 (or separate RT/LT lines, where a payer prefers it), not two units. Billing two units risks an MUE denial and is simply the wrong mechanism. ⚠️ Confirm the current MUE value and bilateral indicator against CMS's own files before building a claim rule on it — this build couldn't retrieve them directly.
The 92133/92134 restriction: CPT instruction, not just a PTP edit
Our main ophthalmology guide flags this pair as the specialty's cleanest bundle that isn't modifier-bypassable, and it's worth being precise about why. CPT's own instructional note under 92134 tells coders not to report 92133 and 92134 together for the same patient, same date, because the two codes are alternative clinical applications of the same SCODI imaging technology — one for the optic nerve head, typically glaucoma; one for the retina, typically macular disease — not two separately performed studies. Current billing-industry sourcing also places the pair in the NCCI PTP edit table, 92133 in Column One and 92134 in Column Two.
⚠️ This build couldn't confirm the current PTP modifier indicator for the pair against CMS's own edit file. Treat it as non-bypassable regardless: the CPT-level instruction applies on its own authority, independent of NCCI, and no modifier indicator undoes an instruction embedded in the code descriptors. Bill whichever code matches what was clinically performed — not both, and not the second "just in case."
Gonioscopy, tonometry, and the "separate procedure" label
Three codes carry the CPT "separate procedure" designation and a bundling history that trips up staff working off the old rule: 92020 (gonioscopy), 92100 (serial tonometry with multiple IOP measurements and interpretation), and 92060 (sensorimotor examination). Medicare bundled all three into eye exam and E/M codes until that policy reversed in 1999; under current Medicare NCCI policy none needs an override modifier alongside an eye exam or E/M code on the same date.
What still makes the claim billable is medical necessity, not the modifier: the visit and the special service need separate, documented diagnostic reasons, not the same complaint captured twice. A reflexive add-on to every comprehensive exam regardless of indication draws the same audit attention as routine 59 use, and a commercial payer that never adopted the 1999 reversal may still edit these as stand-alone-only — confirm the specific payer's current policy rather than assuming it.
The cataract global-period bundling zone
Cataract surgery's 90-day global period is where ophthalmology's bundling logic gets tested hardest, because the deciding factor is a date on the calendar, not which code was billed. Ophthalmic biometry (92136) for IOL power calculation is the clearest example: performed before the decision for surgery was made, it's separately billable on its own date. The identical code, repeated the day before or day of surgery to confirm IOL power, falls inside the global package the same way the pre-operative E/M visit does — billing it again duplicates a service the global fee already covers.
The same logic governs any diagnostic testing during the 90-day post-operative window: a test tied to routine post-op monitoring is bundled, while a test ordered for a new, unrelated finding — documented as such, ideally paired with modifier 24 — is separately billable. The chart has to show the "why" each time; repeating a test at a fixed interval without a new clinical indication turns a legitimately separate service into a bundling denial.
Before writing off a same-day diagnostic test as bundled into the cataract global fee, check the date the decision for surgery was actually documented, not the date the test was run. A study performed genuinely before that documented decision is separate revenue even if it landed close to the surgery date — revenue missed when staff apply the global period as a blanket rule instead of checking the chart's timeline.
Do and don't
- Check the PTP modifier indicator first — indicator 0 ends the question immediately.
- Identify PTP vs. MUE before drafting an appeal; MAI 2 denials can't be appealed at all.
- Document a separate diagnostic reason for gonioscopy or tonometry every time you bill one alongside an eye exam.
- Track the documented decision-for-surgery date separately from the test date on pre-cataract diagnostics.
- Don't bill both 92133 and 92134 same eye, same date — a CPT-level instruction, not a bypassable payer edit.
- Don't bill 67028 as two units for a bilateral same-day injection; use modifier 50, one unit, under the bilateral adjustment.
- Don't assume a commercial payer follows Medicare's NCCI treatment of "separate procedure" codes.
- Don't bill routine pre-cataract biometry performed the day before surgery as separate from the global package.
Losing ophthalmology revenue to bundling denials?
We'll audit a sample of your claims for PTP, MUE, and cataract global-period bundling errors, and show what's recoverable.
Frequently asked questions
Do we need a modifier to bill gonioscopy or tonometry alongside an eye exam?
Not on most carriers, once the record supports a genuinely separate diagnostic reason. Gonioscopy (92020), serial tonometry (92100), and sensorimotor exam (92060) carry the CPT label "separate procedure" and were bundled into eye exam codes until that reversed in 1999; today none needs an override modifier alongside an eye exam or E/M code on most payers. The real requirement is medical necessity: the visit and the special service need distinct diagnostic reasons documented, or a payer that still treats "separate procedure" as stand-alone-only will deny it as incidental. Confirm your carrier's policy rather than assuming the Medicare reversal applies everywhere.
Can we bill IOL biometry (92136) separately if it's performed on the same day as cataract surgery?
Not if it's part of the routine pre-operative workup captured by the 90-day global package. Biometry performed before the decision for surgery was made is separately billable on its own date. The same code repeated the day of or day before surgery to confirm IOL power falls inside the global period the way the pre-op E/M visit does, and billing it separately duplicates a service the global fee already covers. Timing relative to the surgical decision decides it, not which code captured the measurement.
What's the difference between an MUE denial and an NCCI PTP bundling denial?
They're two different mechanisms with different appeal paths. A PTP edit compares two codes billed together and denies the Column Two code unless a supported NCCI-associated modifier overrides it, where the indicator allows an override at all. An MUE caps how many units of a single code are payable on one date, and its MUE Adjudication Indicator (MAI) decides whether that's appealable: MAI 1 is a claim-line edit correctly modified lines can work around; MAI 2 can't be appealed at all; MAI 3 can, with records showing the excess units were genuinely necessary. Knowing which mechanism fired decides whether an appeal is worth drafting.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.